ArticleJournal of Cancer2021

Prognostic Factors of Survival with Aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) as Second-line Therapy for Patients with Metastatic Colorectal Cancer.

Jinchul Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.